420 related articles for article (PubMed ID: 24054994)
1. Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs.
Wychowski T; Wang H; Buniak L; Henry JC; Mohile N
Clin Neurol Neurosurg; 2013 Nov; 115(11):2365-9. PubMed ID: 24054994
[TBL] [Abstract][Full Text] [Related]
2. Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam.
Kruer RM; Harris LH; Goodwin H; Kornbluth J; Thomas KP; Slater LA; Haut ER
J Crit Care; 2013 Oct; 28(5):883.e9-13. PubMed ID: 23566730
[TBL] [Abstract][Full Text] [Related]
3. A retrospective two-center study of antiepileptic prophylaxis in patients with surgically treated high-grade gliomas.
Garbossa D; Panciani PP; Angeleri R; Battaglia L; Tartara F; Ajello M; Agnoletti A; Versari P; Ducati A; Fontanella M; Spena G
Neurol India; 2013; 61(2):131-7. PubMed ID: 23644311
[TBL] [Abstract][Full Text] [Related]
4. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
[TBL] [Abstract][Full Text] [Related]
5. Seizures in patients with glioma treated with phenytoin and levetiracetam.
Merrell RT; Anderson SK; Meyer FB; Lachance DH
J Neurosurg; 2010 Dec; 113(6):1176-81. PubMed ID: 20560728
[TBL] [Abstract][Full Text] [Related]
6. Status epilepticus induction has prolonged effects on the efficacy of antiepileptic drugs in the 6-Hz seizure model.
Leclercq K; Kaminski RM
Epilepsy Behav; 2015 Aug; 49():55-60. PubMed ID: 26123104
[TBL] [Abstract][Full Text] [Related]
7. Use of levetiracetam in hospitalized patients.
Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
[TBL] [Abstract][Full Text] [Related]
8. Tolerability, safety, and side effects of levetiracetam versus phenytoin in intravenous and total prophylactic regimen among craniotomy patients: a prospective randomized study.
Fuller KL; Wang YY; Cook MJ; Murphy MA; D'Souza WJ
Epilepsia; 2013 Jan; 54(1):45-57. PubMed ID: 22738092
[TBL] [Abstract][Full Text] [Related]
9. Impact of seizure activity on free extracellular phenytoin concentrations in amygdala-kindled rats.
Potschka H; Baltes S; Fedrowitz M; Löscher W
Neuropharmacology; 2011; 61(5-6):909-17. PubMed ID: 21736886
[TBL] [Abstract][Full Text] [Related]
10. Practice variations in the management of status epilepticus.
Cook AM; Castle A; Green A; Lesch C; Morrison C; Rhoney D; Parker D; Tesoro E; Brophy G; Goodwin H; Gokun J; Makii J; McAllen K; Bledsoe K; Sangha K; Weant K; Liang N; Murphy-Human T;
Neurocrit Care; 2012 Aug; 17(1):24-30. PubMed ID: 22565631
[TBL] [Abstract][Full Text] [Related]
11. The use of levetiracetam in refractory status epilepticus.
Patel NC; Landan IR; Levin J; Szaflarski J; Wilner AN
Seizure; 2006 Apr; 15(3):137-41. PubMed ID: 16426869
[TBL] [Abstract][Full Text] [Related]
12. Role of intravenous levetiracetam in acute seizure management of children.
Kirmani BF; Crisp ED; Kayani S; Rajab H
Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam may favorably affect seizure outcome after temporal lobectomy.
Jehi LE; Irwin AI; Kayyali H; Vadera S; Bingaman W; Najm I
Epilepsia; 2012 Jun; 53(6):979-86. PubMed ID: 22462729
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drugs in aneurysmal subarachnoid hemorrhage.
Zubkov AY; Wijdicks EF
Rev Neurol Dis; 2008; 5(4):178-81. PubMed ID: 19122570
[TBL] [Abstract][Full Text] [Related]
15. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
McTague A; Kneen R; Kumar R; Spinty S; Appleton R
Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
[TBL] [Abstract][Full Text] [Related]
16. Resistance to phenobarbital extends to phenytoin in a rat model of temporal lobe epilepsy.
Bethmann K; Brandt C; Löscher W
Epilepsia; 2007 Apr; 48(4):816-26. PubMed ID: 17319923
[TBL] [Abstract][Full Text] [Related]
17. Cost-utility analysis of levetiracetam and phenytoin for posttraumatic seizure prophylaxis.
Cotton BA; Kao LS; Kozar R; Holcomb JB
J Trauma; 2011 Aug; 71(2):375-9. PubMed ID: 21825941
[TBL] [Abstract][Full Text] [Related]
18. Intravenous levetiracetam vs phenytoin for status epilepticus and cluster seizures: A prospective, randomized study.
Gujjar AR; Nandhagopal R; Jacob PC; Al-Hashim A; Al-Amrani K; Ganguly SS; Al-Asmi A
Seizure; 2017 Jul; 49():8-12. PubMed ID: 28528211
[TBL] [Abstract][Full Text] [Related]
19. Seizure outcome after AED failure in pediatric focal epilepsy: impact of underlying etiology.
Wirrell EC; Wong-Kisiel LC; Nickels KC
Epilepsy Behav; 2014 May; 34():20-4. PubMed ID: 24681380
[TBL] [Abstract][Full Text] [Related]
20. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam.
Alvarez V; Januel JM; Burnand B; Rossetti AO
Epilepsia; 2011 Jul; 52(7):1292-6. PubMed ID: 21480881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
